COST-EFFECTIVENESS OF RIVAROXABAN COMPAR
COST-EFFECTIVENESS OF RIVAROXABAN COMPARED TO WARFARIN FOR STROKE PROPHYLAXIS IN ATRIAL FIBRILLATION
✍
Soyon Lee; Moise Anglade; Robyn Pisacane; Dan Pham; Jeffrey Kluger; Craig Colema
📂
Article
📅
2012
🏛
Elsevier Science
🌐
English
⚖ 89 KB